Clinical Trial: Perioperative Esketamine for Reducing Post-Thoracoscopic Lung Cancer Surgery Fatigue: A Randomized, Double-Blind, Placebo-Controlled Trial and Inflammatory-Mitochondrial-Endocrine Mediating Mechanism Study (China)

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Perioperative Esketamine for Reducing Post-Thoracoscopic Lung Cancer Surgery Fatigue: A Randomized, Double-Blind, Placebo-Controlled Trial and Inflammatory-Mitochondrial-Endocrine Mediating Mechanism Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130300

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Huai'an First People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=311043

Published by HT Digital Content Services with permission from Health Daily Digest....